Leishmania infantum arginase: biochemical characterization and inhibition by naturally occurring phenolic substances

J Enzyme Inhib Med Chem. 2019 Dec;34(1):1100-1109. doi: 10.1080/14756366.2019.1616182.

Abstract

Inhibition of Leishmania arginase leads to a decrease in parasite growth and infectivity and thus represents an attractive therapeutic strategy. We evaluated the inhibitory potential of selected naturally occurring phenolic substances on Leishmania infantum arginase (ARGLi) and investigated their antileishmanial activity in vivo. ARGLi exhibited a Vmax of 0.28 ± 0.016 mM/min and a Km of 5.1 ± 1.1 mM for L-arginine. The phenylpropanoids rosmarinic acid and caffeic acid (100 µM) showed percentages of inhibition of 71.48 ± 0.85% and 56.98 ± 5.51%, respectively. Moreover, rosmarinic acid and caffeic acid displayed the greatest effects against L. infantum with IC50 values of 57.3 ± 2.65 and 60.8 ± 11 μM for promastigotes, and 7.9 ± 1.7 and 21.9 ± 5.0 µM for intracellular amastigotes, respectively. Only caffeic acid significantly increased nitric oxide production by infected macrophages. Altogether, our results broaden the current spectrum of known arginase inhibitors and revealed promising drug candidates for the therapy of visceral leishmaniasis.

Keywords: arginase; caffeic acid; inhibitor; rosmarinic acid; visceral leishmaniasis.

MeSH terms

  • Animals
  • Antiprotozoal Agents / chemistry
  • Antiprotozoal Agents / pharmacology*
  • Arginase / antagonists & inhibitors*
  • Arginase / metabolism
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Leishmania infantum / drug effects*
  • Leishmania infantum / enzymology
  • Leishmania infantum / growth & development
  • Macrophages / drug effects
  • Macrophages / parasitology
  • Mice
  • Mice, Inbred BALB C
  • Models, Molecular
  • Molecular Structure
  • Parasitic Sensitivity Tests
  • Phenols / chemistry
  • Phenols / pharmacology*
  • RAW 264.7 Cells
  • Structure-Activity Relationship

Substances

  • Antiprotozoal Agents
  • Enzyme Inhibitors
  • Phenols
  • Arginase

Grants and funding

This work was supported by grants from Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional Cientıfico e Tecnologico (CNPq) and PROEP/CNPq 407856/17, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and by a Brazil Initiative Collaboration Grant from Brown University. ARG is recipient of a Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) graduate fellowship.